Brief: Dyadic International - Develops C1 Cell Lines And Manufactures Bundibugyo Ebolavirus Antigens Within 15 Days
28/07/2026 13:50
BRIEF-Dyadic International - Develops C1 Cell Lines And Manufactures Bundibugyo Ebolavirus Antigens Within 15 Days July 28 (Reuters) - Dyadic International Inc DYAI.O:
DYADIC INTERNATIONAL - DEVELOPS C1 CELL LINES AND MANUFACTURES BUNDIBUGYO EBOLAVIRUS ANTIGENS WITHIN 15 DAYS
DYADIC INTERNATIONAL - DELIVERS C1-PRODUCED BUNDIBUGYO EBOLAVIRUS ANTIGENS TO FBS AND SCRIPPS FOR PRECLINICAL EVALUATION
Source text: ID:nGNEl3d93
Further company coverage: DYAI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dyadic International
See all newsDyadic International Inc reports results for the quarter ended June 30 - Earnings Summary
Dyadic International Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Dyadic International - Develops C1 Cell Lines And Manufactures Bundibugyo Ebolavirus Antigens Within 15 Days
Brief: Dyadic Announces Continued Listing On The Nasdaq Capital Market
Brief: Dyadic And Scripps Research Collaborate On Rapid-Response Hantavirus Antibody And Vaccine Development